Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,433,123
-
Share change
-
-1,724,453
-
Total reported value
-
$54,974,536
-
Price per share
-
$2.25
-
Number of holders
-
47
-
Value change
-
-$3,097,138
-
Number of buys
-
27
-
Number of sells
-
17
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q4 2020
As of 31 Dec 2020,
LEAP THERAPEUTICS INC - COM (LPTX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,433,123 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, HILLHOUSE CAPITAL ADVISORS, LTD., Artal Group S.A., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, Affinity Asset Advisors, LLC, SPHERA FUNDS MANAGEMENT LTD., TWO SIGMA ADVISERS, LP, BAKER BROS. ADVISORS LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.